Antibodies to N-methyl-D-aspartate glutamate receptors in Creutzfeldt-Jakob disease patients

Journal of Neuroimmunology

Volumn 251, Issue 1-2, 2012, Pages 90-93

  Fujita, Koji ^a   Yuasa, Tatsuhiko ^b   Takahashi, Yukitoshi ^c   Tanaka, Keiko ^d   Sako, Wataru ^a   Koizumi, Hidetaka ^a,e   Iwasaki, Yasushi ^f   Yoshida, Mari ^f   Izumi, Yuishin ^a   Kaji, Ryuji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b Kamagaya General Hospital   (Japan)

^c SHIZUOKA INSTITUTE OF EPILEPSY AND NEUROLOGICAL DISORDERS   (Japan)

^d KANAZAWA MEDICAL UNIVERSITY   (Japan)

^e KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^f AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Autoantibodies; Creutzfeldt Jakob disease; N methyl D aspartate glutamate receptors

Indexed keywords

AUTOANTIBODY; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECEPTOR ANTIBODY;

ADULT; AGED; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SPORADIC CREUTZFELDT JAKOB DISEASE;

AGED; AGED, 80 AND OVER; ANIMALS; AUTOANTIBODIES; CREUTZFELDT-JAKOB SYNDROME; FEMALE; HIPPOCAMPUS; HUMANS; LIMBIC ENCEPHALITIS; MALE; MIDDLE AGED; RATS; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84865619727     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2012.06.010     Document Type: Article

References (15)

1. Chitravas N., Jung R.S., Kofskey D.M., Blevins J.E., Gambetti P., Leigh R.J., Cohen M.L. Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease. Ann. Neurol. 2011, 70:437-444.
2. Dalmau J., Lancaster E., Martinez-Hernandez E., Rosenfeld M.R., Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011, 10:63-74.
3. Drayton D.L., Liao S., Mounzer R.H., Ruddle N.H. Lymphoid organ development: from ontogeny to neogenesis. Nat. Immunol. 2006, 7:344-353.
4. Fujita K., Yuasa T., Takahashi Y., Tanaka K., Hashiguchi S., Adachi K., Izumi Y., Kaji R. Detection of anti-glutamate receptor ε2 and anti-N-methyl-D-aspartate receptor antibodies in a patient with sporadic Creutzfeldt-Jakob disease. J. Neurol. 2012, 259:985-988.
5. Fujita K., Yuasa T., Watanabe O., Takahashi Y., Hashiguchi S., Adachi K., Izumi Y., Kaji R. Voltage-gated potassium channel complex antibodies in Creutzfeldt-Jakob disease. J. Neurol. 2012, 10.1007/s00415-012-6554-y.
6. Geschwind M.D., Tan K.M., Lennon V.A., Barajas R.F., Haman A., Klein C.J., Josephson S.A., Pittock S.J. Voltage-gated potassium channel autoimmunity mimicking Creutzfeldt-Jakob disease. Arch. Neurol. 2008, 65:1341-1346.
7. Goverman J. Autoimmune T cell responses in the central nervous system. Nat. Rev. Immunol. 2009, 9:393-407.
8. Kaufman D.L., Clare-Salzier M., Tian J., Forsthuber T., Ting G.S., Robinson P., Atkinson M.A., Sercarz E.E., Tobin A.J., Lehmann P.V. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993, 366:69-72.
9. Lewicki H., Tishon A., Homann D., Mazarguil H., Laval F., Asensio V.C., Campbell I.L., DeArmond S., Coon B., Teng C., Gairin J.E., Oldstone M.B. T cells infiltrate the brain in murine and human transmissible spongiform encephalopathies. J. Virol. 2003, 77:3799-3808.
10. Seipelt M., Zerr I., Nau R., Mollenhauer B., Kropp S., Steinhoff B.J., Wilhelm-Gössling C., Bamberg C., Janzen R.W., Berlit P., Manz F., Felgenhauer K., Poser S. Hashimoto's encephalitis as a differential diagnosis of Creutzfeldt-Jakob disease. J. Neurol. Neurosurg. Psychiatry 1999, 66:172-176.
11. Sotelo J., Gibbs C.J., Gajdusek D.C. Autoantibodies against axonal neurofilaments in patients with kuru and Creutzfeldt-Jakob disease. Science 1980, 210:190-193.
12. Toh B.H., Gibbs C.J., Gajdusek D.C., Goudsmit J., Dahl D. The 200- and 150-kDa neurofilament proteins react with IgG autoantibodies from patients with kuru, Creutzfeldt-Jakob disease, and other neurologic diseases. Proc. Natl. Acad. Sci. U. S. A. 1985, 82:3485-3489.
13. Wall C.A., Rummans T.A., Aksamit A.J., Krahn L.E., Pankratz V.S. Psychiatric manifestations of Creutzfeldt-Jakob disease: a 25-year analysis. J. Neuropsychiatry Clin. Neurosci. 2005, 17:489-495.
14. World Health Organization Human transmissible spongiform encephalopathies. WHO Wkly. Epidemiol. Rec. 1998, 73:361-372.
15. Yoneda M., Fujii A., Ito A., Yokoyama H., Nakagawa H., Kuriyama M. High prevalence of serum autoantibodies against the amino terminal of α-enolase in Hashimoto's encephalopathy. J. Neuroimmunol. 2007, 185:195-200.